Jozal Moore, M.D.

About Me

Dr. Moore is a native of upstate New York and is committed to providing the best available therapies and compassionate care to patients in this region. To accomplish this, she believes in honest communication to ensure that treatments are driven both by clinical expertise and each patients' individu...

Dr. Moore is a native of upstate New York and is committed to providing the best available therapies and compassionate care to patients in this region. To accomplish this, she believes in honest communication to ensure that treatments are driven both by clinical expertise and each patients' individual needs. Dr. Moore is involved in clinical research in myeloid malignancies, stem cell transplantation, and the bone marrow microenvironment, to help improve outcomes and bring better treatment options to patients with hematologic malignancies and other blood disorders.

Conditions I Treat:
- Acute Leukemias,
- Myelodysplastic Neoplasms
- Myeloproliferative Neoplasms
- Stem Cell Transplantation & Cellular Therapies

Professional Background

Dr. Moore received her bachelor's degree with magna cum laude honors from the University of Rochester, and completed her graduate medical training at the University of Rochester School of Medicine. She completed internship and residency at Brown University in Providence, RI, and returned to the Univ...

Dr. Moore received her bachelor's degree with magna cum laude honors from the University of Rochester, and completed her graduate medical training at the University of Rochester School of Medicine. She completed internship and residency at Brown University in Providence, RI, and returned to the University of Rochester for Hematology and Oncology fellowship, where she additionally served as a chief fellow. Dr. Moore is certified by the American Board of Internal Medicine.

Faculty Appointments

Assistant Professor - Department of Medicine, Hematology/Oncology (SMD)

Credentials

Residency & Fellowship

Fellowship, Hematology & Oncology, University of Rochester Medical Center. 2020 - 2023

Residency, Internal Medicine, Brown University Medical School-GME. 2017 - 2020

Education

MD | University of Rochester School of Medicine/Dentistry. 2017

Awards

John & Carol Bennett Research Award. 2022

Segel-Halterman Fellowship Award for Scholarship in Hematology. 2021 - 2022

Award for Exemplary Primary Care. 2020

Excellence in Teaching Award. 2019

University of Rochester School of Medicine Summer Research Fellowship. 2014

Dean's Merit Scholarship Award. 2013 - 2017

Publications

Journal Articles

How Genetics Can Drive Initial Therapy Choices for Older Patients with Acute Myeloid Leukemia.

Moore JW, Torres N, Superdock M, Mendler JH, Loh KP

Current treatment options in oncology.. 2022 June 10 Epub 06/10/2022.

Tumor lysis syndrome risk in outpatient versus inpatient administration of venetoclax and hypomethlators for acute myeloid leukemia.

Pelcovits A, Moore J, Bakow B, Niroula R, Egan P, Reagan JL

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer.. 2021 September 29 (9):5323-5327. Epub 03/04/2021.

False-positive heparin-PF4 latex immunoturbidimetric assay due to lupus anti-coagulant interference: a case report.

McRae HL, Moore JW, Ifthikharuddin JJ, Refaai MA

British journal of haematology.. 2021 April 20 Epub 04/20/2021.

Azacitidine and Venetoclax in AML.

Moore JW, Pelcovits A, Reagan JL

The New England journal of medicine.. 2020 November 19383 (21):2088. Epub 1900 01 01.

Books

Ferri's Clinical Advisor (2020)

Chapter: Antiphospholipid antibody syndrome

Authors: Waroich (Moore) J, Reagan JL

Publisher: Elsevier, Philadelphia, PA 2020

Ferri's Clinical Advisor (2019)